Novavax says COVID vaccine for U.S. to be manufactured by India’s Serum

2022.06.07 22:00

2/2

FILE PHOTO: Vials labelled “VACCINE Coronavirus COVID-19” and a syringe are seen in front of a displayed Novavax logo in this illustration taken December 11, 2021. REUTERS/Dado Ruvic/Illustration

2/2

(Reuters) – Novavax (NASDAQ:NVAX) Inc said on Tuesday that its COVID-19 vaccine initially available in the United States, if authorized, will be manufactured by the Serum Institute of India.

“So all vaccines that are being distributed globally commercially are being made in a single facility by our partners (the Serum Institute in India) that includes the vaccines which are being deployed around the world as well as the ones that will be initially deployed in the U.S.,” said Chief Medical Officer Filip Dubovsky.

Source